Cannabinoid interacts with serotonin to promote calm
The secret is out. All over the US (and the world), patients and consumers are zoning in on cannabidiol (CBD) in droves. While policymakers continue to redirect the conversation toward its potential risks, many have already incorporated CBD into their daily medical and wellness regimen. But politicians are not the only ones hitting pause on the giant shiny button that is CBD—it’s researchers, too, although their concerns are quite different.
When it comes to cannabinoid medicine, patient-reported outcomes are far ahead of the science. And that’s thanks of course to long-standing prohibition that has made research on the plant so incredibly difficult. Now that hemp-based CBD is everywhere and medical cannabis programs are growing, researchers are playing catch up on their understanding of the mechanisms underlying the multiple cited benefits of cannabinoids.
Many patients and consumers cite anxiety and stress as…
View original post 474 more words